Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

188
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
188
Human Genetics01:28

Human Genetics

470
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
470
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

160
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
160

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fecal metabolome alterations in infants at risk of developing allergies during the first year of life.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

Mucin Type Drives Composition and Mucin Glycan Degradation of an In Vitro Synthetic Microbial Community.

Environmental microbiology·2026
Same author

Acsl4-mediated Lipid Homeostasis Orchestrates Synaptic and Cognitive Plasticity.

Research square·2026
Same author

Association of Polygenic Risk Scores With Aortic Valve Calcium: The Multi-Ethnic Study of Atherosclerosis.

Journal of the American Heart Association·2026
Same author

Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program.

Atherosclerosis·2026
Same author

Metabolic modeling unveils potential probiotic roles of <i>Flavonifractor plautii</i> in reshaping the Western gut microbiota landscape.

ISME communications·2026

Related Experiment Video

Updated: May 9, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.6K

Multi-omics approach identifies gut microbiota variations associated with depression.

Adrián Hernández-Cacho1,2,3, Jesús F García-Gavilán4,5,6, Alessandro Atzeni1,2,3

  • 1Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Alimentació, Nutrició, Desenvolupament i Salut Mental ANUT-DSM, Reus, Spain.

NPJ Biofilms and Microbiomes
|April 28, 2025
PubMed
Summary

Depression is linked to significant changes in gut bacteria and their metabolites, suggesting a role for the gut microbiome in mental health. Further research is needed to confirm if these gut alterations cause or result from depression.

More Related Videos

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
06:23

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota

Published on: February 15, 2019

13.8K
Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
07:49

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice

Published on: June 2, 2022

3.1K

Related Experiment Videos

Last Updated: May 9, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.6K
Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
06:23

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota

Published on: February 15, 2019

13.8K
Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
07:49

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice

Published on: June 2, 2022

3.1K

Area of Science:

  • Microbiology
  • Neuroscience
  • Metabolomics

Background:

  • The gut microbiota influences the gut-brain axis, potentially playing a role in depression.
  • Understanding this connection is crucial for developing novel therapeutic strategies for mental health disorders.

Purpose of the Study:

  • To investigate the relationship between gut microbiota composition, fecal metabolites, and depression in a large cohort.
  • To explore the gut-brain axis interplay in the context of depression using a multi-omics approach.

Main Methods:

  • Cross-sectional study of 400 participants from the PREDIMED-Plus study.
  • Depression assessment via antidepressant use or Beck Depression Inventory-II scores.
  • Gut microbiota analysis using 16S rRNA sequencing and fecal metabolite profiling via LC-MS/MS.

Main Results:

  • Significant differences in gut microbial composition and metabolic profiles were observed in participants with depression.
  • Key altered microbial taxa included Acidaminococcus, Christensenellaceae R-7 group, and Megasphaera.
  • Fifteen significantly altered metabolites, including lipids, organic acids, and benzenoids, were identified, with some correlating to microbial features.

Conclusions:

  • The gut microbiota and its metabolic output are significantly altered in individuals with depression.
  • These findings underscore the complex interplay between the gut microbiome and depression.
  • Further research is warranted to elucidate the causal relationship and therapeutic potential.